Tekrardan Hoşgeldiniz
Cointime'ın Hizmet Şartları'ini kabul etmek ve Cointime'ın Gizlilik Politikası'inin sizin için geçerli olduğunu onaylamak için "Giriş "a tıklayın.
Cointime’a Katıl
Çoktan Hesabın Var mı?
Cointime'ın <a class="underline" href="#term-of-service">Hizmet Şartları</a>'ini kabul etmek ve Cointime'ın a class="underline" href="#privacy-policy">Gizlilik Politikası</a>'inin sizin için geçerli olduğunu onaylamak için "page.Sign up "a tıklayın.
Giriş Yap
Kayıt Ol
Posta kutunuz
Gelen kutunuzu kontrol edin
Giriş yapmak için emaildeki bağlantıya tıklayın.
Kayıt olmak için emaildeki bağlantıya tıklayın.
Advion Inc.
company
About
Advion is a company that offers the expression family of compact mass spectrometers designed for the chemist.
- 51 - 100
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $15M
- Industries
- Biotechnology,Pharmaceutical,Therapeutics
- Founded date
- Jan 1, 1993
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Advion is a global company that offers a variety of systems and consumables for life science research. Its clientele is comprised of pharmaceutical companies, government life science research agencies, and universities.Advion provides a diverse portfolio of microfluidic and mass spec-based products for the life science industry. It was founded in 1993.The company is headquartered in New York, United States.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$15M
Advion Inc. has raised a total of
$15M
in funding over 2 rounds. Their latest funding was raised on
May 9, 2002 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 9, 2002 | Series B | $15M | 1 |
Perseus-Soros Biopharmaceutical Fund
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Advion Inc. is funded by 1 investors.
Perseus-Soros Biopharmaceutical Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Perseus-Soros Biopharmaceutical Fund
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
